The_Hagedorn_Prize

The Hagedorn Prize

The Hagedorn Prize

Medical research prize

The Hagedorn Prize is an annual award within the field of medical research, specifically recognizing outstanding contributions to diabetes research and endocrinology. Named after Hans Christian Hagedorn, a renowned Danish scientist and co-founder of Nordisk Insulinlaboratorium[1] (now part of Novo Nordisk), the prize celebrates achievements in the understanding and treatment of diabetes.[2]

Hagedorn's work significantly advanced the quality of insulin production and diabetes care, making this award a tribute to his legacy in the field. The Hagedorn Prize is recognised as the most prestigious award in Internal medicine in Denmark.[3]

Background

History

The Hagedorn Prize was established by the Danish Society of Internal Medicine in 1966 to recognize the contribution to medical science made by Hans Christian Hagedorn (1888–1971).[4] The prize is awarded at the society's annual general meeting.[5]

Initially, the Hagedorn Prize received its endowment from a distinct foundation, funded by contributions from Nordisk Insulinlaboratorium, with the Board of the Danish Society for Internal Medicine serving as its governing body. However, by 2008, the foundation's resources were deemed inadequate to sustain a meaningful award. Consequently, the remaining capital was transferred to the Novo Nordisk Foundation, which subsequently assumed the responsibility of bestowing the Hagedorn Prize, while maintaining the ongoing involvement of the Society. The recipient of the prize is determined by the society's board, relying on recommendations provided by its members.[5]

About the Danish Society of Internal Medicine

The Danish Society of Internal Medicine, comprising nearly 4,500 members, serves as an overarching body for the nine internal medicine specialties within Denmark. Its objectives include the advancement of scientific research in internal medicine and the facilitation of ongoing education for specialist physicians in the discipline. Established in 1916, the Society operates with a board of directors composed of nine members, appointed by the boards of each respective internal medicine specialty.[6]

Award

The Hagedorn Prize includes a monetary component, designed to support the ongoing research of the recipient. In addition, awardees are presented with a medal and a certificate recognizing their contributions to advancing diabetes research and treatment. The prize is intended not only to honor individuals for their past achievements but also to encourage further innovation and research in diabetes care.[5]

Recipients

List of recipients of The Hagedorn Prize[7]

More information Year, Recipient ...

References

  1. [1]
    "Crash course – 2023 Nobel Prizes". NobelPrize.org. 27 November 2023. Retrieved 2024-04-09.
  2. [2]
    Bærnholdt. "History". Steno Website. Retrieved 2024-04-09.
  3. [3]
    "The Hagedorn Medal and Prize". Research Explorer The University of Manchester. Retrieved 2024-04-09.
  4. [4]
    Rydén, Lars; Lindsten, Jan (May 2021). "The history of the Nobel prize for the discovery of insulin". Diabetes Research and Clinical Practice. 175: 108819. doi:10.1016/j.diabres.2021.108819. PMID 33865917.
  5. [5]
    "The Hagedorn Prize". Novo Nordisk Fonden. Retrieved 2024-04-09.
  6. [6]
    "Internationally acclaimed Danish virologist receives the 2022 Hagedorn Prize". Novo Nordisk Fonden. Retrieved 2024-04-09.
  7. [7]
    "Prize recipients Archive". Novo Nordisk Fonden. Retrieved 2024-04-09.
  8. [8]
    Malassé, Charlotte (2022-03-03). "Internationally acclaimed Danish virologist receives the 2022 Hagedorn Prize". isim.ku.dk. Retrieved 2024-04-09.
Share this article:

This article uses material from the Wikipedia article The_Hagedorn_Prize, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.